Mounjaro Prices Rising: What UK Patients Need to Know

Free consultation, reviewed the same working day by a GPhC-registered Independent Prescriber
Prescription included — no separate charge, no hidden fee
Free next-working-day DPD delivery in plain, unbranded packaging once approved
Priority aftercare seven days a week, with clinical re-review before every repeat order

Mounjaro prices in the UK rose sharply from 1 September 2025, after Eli Lilly increased its list price across the range. The highest-dose pen moved from roughly £122 to around £330 per four-week supply, and private clinic prices have followed suit. If you have noticed the cost climbing, you are not imagining it. Mounjaro is a prescription-only medicine, which means it cannot legally be sold, advertised or obtained without a clinical assessment by a qualified prescriber — and that clinical layer is part of what you are paying for, wherever you go.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How the price increase happened, what it covers, and how to make sense of what you are quoted

Step 1: Understand what actually changed in September 2025

Eli Lilly restructured Mounjaro's UK list price on 1 September 2025. Before that date, the highest-dose pen carried a list price of around £122. After it, that same pen was priced at roughly £330. As widely reported at the time, the earlier price had been set as a managed-entry point while Mounjaro was new to the UK market; the September revision brought it closer to prices seen in comparable European countries.

For anyone already on treatment, this was significant. A question our prescribers hear most weeks is whether the price is going to keep rising, or whether this was a one-off correction. Honestly, no one can say with certainty, and if you want to understand the outlook, our page on whether Mounjaro prices are set to rise further looks at what we know. What is clear is that Mounjaro prices going up was a deliberate commercial decision by the manufacturer, not a supply-chain anomaly. Private providers passed the increase through to their treatment prices, which is why the figure you see quoted today will look very different from one you might have noted a year ago.

The increase affected the whole range, though not proportionally. If you want to understand how the shift played out across individual doses, including a closer look at what 5mg Mounjaro costs following the restructure, the full Mounjaro UK pricing picture covers that in more detail. The short version: the lower starter doses rose less steeply in absolute terms, but no dose was left unchanged.

Step 2: Read the headline price carefully, it often tells only part of the story

Private Mounjaro prices are typically quoted per pen or per month. Reported private market figures since September 2025 range from roughly £149 to £375 a month, depending on dose and provider. That spread is wide, and it reflects real differences in what is and is not included.

A headline price from some providers covers the pen alone. Consultation fees, prescription charges and delivery costs appear separately, sometimes at checkout, sometimes only if you look for them. Dose-review support, aftercare access and repeat-prescription reviews may be billed as add-ons or simply absent. When you are comparing figures, it is worth asking what the total cost of a month's treatment actually is, not just the cost of the medicine itself.

The breakdown of what drives Mounjaro pen pricing in the UK goes into this further if you want the granular version. For now, the practical point is this: two providers quoting similar figures may be offering very different levels of clinical oversight. For a prescription-only medicine with a titration schedule managed by a prescriber, that distinction matters.

Step 3: Know what nume's price actually covers

At nume, sorry, at nume, one transparent price covers the consultation, the prescription, the treatment itself and free next-working-day tracked delivery. There are no subscription charges, no automatic renewals and no separate clinical fees. Before every repeat order, a GPhC-registered prescriber reviews your case again, not a questionnaire scoring algorithm, but a named clinician reading your information. That review is included.

We are not the cheapest option in the market. That is a deliberate choice. The clinical infrastructure that makes treatment safe (identity verification, live weight checks, GP notification, evidence review at each dose step) adds cost, and we do not strip it out to win a price comparison. What a lower headline number sometimes represents is a thinner process. For a medicine like Mounjaro, a thinner process is not a saving; it is a risk.

If you want to see what treatment through nume's weight-loss service (nume's weight-loss service) involves in practice, the treatment page sets it out. The price shown there is the price you pay.

Step 4: Price is the wrong filter for a prescription medicine

The MHRA has warned publicly and repeatedly about counterfeit weight-loss pens sold through social media and unofficial websites. In a 2025 enforcement operation, investigators seized roughly 20 million doses of illegally traded weight-loss medicines with an estimated street value of around £45 million. A first illicit manufacturing site producing fake tirzepatide pens was raided in Northampton in October 2025. Counterfeit pens have contained insulin in place of tirzepatide, with serious consequences for patients who used them.

The sellers behind those products often advertise prices well below anything a legitimate licensed pharmacy can offer. If a price looks startlingly low, that gap is worth interrogating before you hand over payment details. Any registered UK online pharmacy can be checked in seconds on the GPhC pharmacy register. A seller offering Mounjaro without a prescription-based clinical assessment, regardless of how credible their site looks, is operating outside the law.

For more context on how to evaluate what you are being offered, the Mounjaro pricing guide covers the legitimacy signals that matter. The right question when Mounjaro prices are rising is not where to find the lowest number, it is where to find genuine medicine, dispensed legally, reviewed by a real prescriber. That question has a much shorter list of answers.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions